Table 1.
Characteristics of the study population by gender.
| Characteristics | Male (n = 847) | Female (n = 577) | p-valuea |
|---|---|---|---|
| Age, median (IQR) | 68 (19) | 72 (23) | 0.011 |
| COVID-19 vaccination | 44.3% | 43.5% | 0.735 |
| Prevalence of Comorbidities | |||
| Cancer | 4.7% | 4.9% | 0.910 |
| Diabetes | 26.3% | 18.0% | <0.001 |
| CVD | 64.6% | 67.1% | 0.332 |
| HIV infection | 1.4% | 1.4% | 0.962 |
| Chronic Respiratory Disease | 18.5% | 16.8% | 0.404 |
| Kidney Disease | 8.0% | 7.1% | 0.520 |
| Other Metabolic Disease | 9.9% | 14.7% | 0.006 |
| Liver Disease | 0.7% | 0.2% | 0.156 |
| Chronic Neurological Disease | 15.2% | 16.8% | 0.423 |
| Obesity | 11.4% | 14.9% | 0.062 |
| Outcomes | |||
| Hospitalization | 38.8% | 37.6% | 0.436 |
| Residential facility | 8.4% | 9.4% | |
| Treatment at home | 52.6% | 53.1% | |
| Drug therapy | 11.3% | 7.1% | 0.004 |
| Intubation | 6.3% | 3.5% | 0.011 |
| Death | 36.5% | 32.8% | 0.141 |
Abbreviations: CVD, cardiovascular diseases; HIV, Human Immunodeficiency Virus.
a
Results are based on the Mann–Whitney U test for continuous variables, and the Chi-Squared test for those categorical.